Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Best Momentum Stock to Buy for December 8th
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, December 8th:
BrightSpire Capital (BRSP - Free Report) : This commercial real estate credit REIT which, is focused on originating, acquiring, financing and managing a diversified portfolio consisting primarily of CRE debt investments and net leased properties predominantly in the United States, has a Zacks Rank #1 (Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.1% over the last 60 days.
BrightSpire Capital, Inc. Price and Consensus
BrightSpire Capital, Inc. price-consensus-chart | BrightSpire Capital, Inc. Quote
BrightSpire Capital’s shares gained 2.6% over the last three month compared with the S&P 500’s gain of 1.2%. The company possesses a Momentum Score of A.
BrightSpire Capital, Inc. Price
BrightSpire Capital, Inc. price | BrightSpire Capital, Inc. Quote
Rigel Pharmaceuticals (RIGL - Free Report) : This company which, is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.9% over the last 60 days.
Rigel Pharmaceuticals, Inc. Price and Consensus
Rigel Pharmaceuticals, Inc. price-consensus-chart | Rigel Pharmaceuticals, Inc. Quote
Rigel Pharmaceuticals’ shares gained 1.8% over the last three month compared with the S&P 500’s gain of 1.2%. The company possesses a Momentum Score of A.
Rigel Pharmaceuticals, Inc. Price
Rigel Pharmaceuticals, Inc. price | Rigel Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.